WCLC 2023: Nivolumab Plus Ipilimumab Improves Survival, Quality of Life in Metastatic NSCLC
The immunotherapy performed better than traditional chemotherapy
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.